Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
Rachid Abaji,1 Maja Krajinovic2 1Department of Pharmacology, 2Departments of Pediatrics and Pharmacology, CHU Sainte-Justine Research Center, University of Montreal, Montreal, QC, Canada Abstract: The thiopurine S-methyltransferase (TPMT) gene encodes for the TPMT enzyme that plays a crucial role in...
Main Authors: | Abaji R, Krajinovic M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-05-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/thiopurine-s-methyltransferase-polymorphisms-in-acute-lymphoblastic-le-peer-reviewed-article-PGPM |
Similar Items
-
gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
by: Katsuyoshi Matsuoka
Published: (2020-07-01) -
Establishment of human lymphoma cell lines with different thiopurine S-methyltransferase (TPMT) activities and differential proteome analysis after thiopurine exposure.
by: Misdaq, Misbah
Published: (2013) -
Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
by: Raphael P. Luber, et al.
Published: (2019-11-01) -
A Practical Non-Extraction Direct Liquid Chromatography Method for Determination of Thiopurine S-Methyltransferase Activity in Inflammatory Bowel Disease
by: Fariborz Bahrehmand, et al.
Published: (2017-08-01) -
Importance of <i>NUDT15</i> Polymorphisms in Thiopurine Treatments
by: Yoichi Tanaka, et al.
Published: (2021-08-01)